Lisocabtagene maraleucel for treating relapsed or refractory aggressive B-cell non-Hodgkin lymphoma after 1 systemic treatment when a stem cell transplant is unsuitable (terminated appraisal)
Technology appraisal
Reference number: TA1083
Published:
Tools and resources
Tools and resources to help you put the guidance into practice.